RecruitingNCT07264959
Rare condition
Indolent systemic mastocytosis
5
studies recruiting now
as of 7 Sept 2026
22
studies registered in total
as of 7 Sept 2026
23
countries with a recruiting site
as of 7 Sept 2026
4 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06210698
Angioedema Biomarker Research Study
RecruitingPhase 2 / Phase 3NCT04910685
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
RecruitingNCT07255638
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
RecruitingPhase 4NCT06748001
Avapritinib Rollover Study
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Indolent systemic mastocytosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Indolent systemic mastocytosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Indolent systemic mastocytosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).